DEANXIT

This brand name is authorized in Austria, Cyprus, Hong Kong SAR China, Malta, Singapore, Spain.

Active ingredients

The drug DEANXIT contains a combination of these active pharmaceutical ingredients (APIs):

1	Melitracen UNII J3448GKP5W - MELITRACEN HYDROCHLORIDE
	Melitracen is a tricyclic antidepressant with activating properties in low doses. It has similar pharmacological properties as amitriptyline but is less sedative.
	Read more about Melitracen
2	Flupentixol UNII HAT84MLQ6Z - FLUPENTIXOL DIHYDROCHLORIDE
	Read more about Flupentixol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEANXIT Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06CA02	Melitracen and psycholeptics	N Nervous system → N06 Psychoanaleptics → N06C Psycholeptics and psychoanaleptics in combination → N06CA Antidepressants in combination with psycholeptics
Discover more medicines within N06CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	50102
HK	Department of Health Drug Office	19697
MT	Medicines Authority	MA601/00401, PI908/04601A
SG	Health Sciences Authority	00913P